Animal Feed Enzymes Market Size & Share 2026-2035

Animal Feed Enzymes Market Size

The animal feed enzymes market was valued at USD 1.52 billion in 2025, advancing to USD 1.62 billion in 2026, and is projected to grow at a 6.7% CAGR from 2026 to 2035, reaching USD 2.92 billion by 2035.

The Animal Feed Enzymes Market serves compound-feed and premix formulation through exogenous phytase, carbohydrase, protease, lipase, oxidase, and multi-enzyme preparations. Demand is increasingly tied to feed-cost management, nutrient-release targets, and lower excretion intensity. Blended ex-factory pricing was approximately USD 8,288 per metric ton in 2025, while the product mix is shifting toward higher-volume carbohydrase and protease formulations with lower average selling prices than concentrated phytase products.

Animal Feed Enzymes Market Trends, Growth Drivers & GMI Forecast Outlook

Feed-output expansion, reformulation toward variable plant-protein inputs, and regulatory pressure on nutrient losses underpin demand for enzyme solutions. The outlook remains differentiated by species and geography: established poultry and swine programs favor product upgrades, while aquaculture and developing commercial-feed systems widen the addressable use base.

Key Drivers

*Evidence note: Historic and current signals inform GMI’s proprietary forecast assumptions.*

Aquaculture is becoming a particularly important source of demand because commercial diets are moving away from fishmeal and toward soy protein concentrate, rapeseed meal, wheat gluten, and pulse-based ingredients. These substitutions change the antinutritional profile of feed formulations and increase the commercial value of coordinated phytase, protease, and carbohydrase programs. Global aquaculture feed output reached 55.47 million metric tons in 2025 and increased by 4.7% year on year, underscoring the scale of the formulation transition facing feed producers.

Regulatory development also supports demand by turning enzyme performance into an addressable, species-specific commercial proposition. In the European Union, feed enzymes require a safety and efficacy review through the applicable additive authorization process, creating a significant qualification threshold for suppliers but also strengthening the commercial value of an approved label extension ^[2]. Companies with established dossiers, technical service resources, and multi-species trial capability are better positioned to convert regulatory access into recurring feed-mill adoption.

Key Restraints

*Evidence note: Historic and current signals inform GMI’s proprietary forecast assumptions.*

The restraint profile is most visible in mature poultry and swine markets, where phytase inclusion is already embedded in standard feed programs. In those settings, suppliers must win demand through improved matrix values, greater heat stability, stronger technical support, or a broader enzyme package rather than through first-time adoption. A slower feed-production environment therefore has an outsized effect on suppliers whose portfolios are concentrated in legacy, high-penetration applications.

Thermostability is a separate constraint because it affects the practical conversion of formulation intent into biological performance. Pellet durability and pathogen control make thermal processing indispensable in many compound-feed systems, but heat exposure can compromise enzyme activity before feed reaches the animal. Suppliers that combine stable enzyme variants with workable coating or liquid-application systems can reduce that implementation friction and protect the commercial case for more sophisticated enzyme programs.^[7]

Animal Feed Enzymes Market Segment Analysis

By Enzyme Type

The Animal Feed Enzymes Market is segmented by enzyme type according to the nutritional substrate being targeted, the formulation complexity required, and the degree of feed-mill adoption across animal species.

Phytases generated USD 655 million in 2025 and are projected to reach USD 1.05 billion by 2035. Phytases remain the category anchor because they release phosphorus and associated minerals bound in phytate, supporting lower inorganic-phosphate use and improved nutrient utilization in monogastric diets. Their future demand is increasingly tied to application expansion and upgraded product performance rather than basic adoption, as established poultry and swine customers already treat phytase as a standard formulation input.

Carbohydrases generated USD 488 million in 2025 and are projected to grow at a 7.9% CAGR from 2026 to 2035. Carbohydrase demand benefits from the diversity of non-starch polysaccharides in wheat, rye, barley, oats, soybean meal, palm-kernel meal, and other regionally sourced ingredients. Feed formulators can adapt these enzymes to changing grain and co-product availability, making the category well suited to cost-sensitive rations that rely on a more varied ingredient basket.

Proteases accounted for a 15.0% share of market revenue in 2025 and are projected to reach USD 497 million by 2035. Proteases are gaining commercial relevance as diets incorporate alternative proteins, including processed animal proteins, fermented ingredients, single-cell proteins, and insect-derived inputs. Their value proposition extends beyond digestibility: they can support matrix reductions in dietary crude protein, which can improve feed economics while helping producers manage nitrogen output.

Others are projected to account for a 14.0% share of market revenue by 2035 and grow at an 11.5% CAGR from 2026 to 2035. This category includes lipases, oxidases, and multi-enzyme complexes designed to address several antinutritional factors within one formulation. The commercial attraction is operational as well as nutritional: integrated enzyme systems can simplify dosing, reduce compatibility concerns, and offer feed mills a more coherent response to complex raw-material profiles.

By Application

The Animal Feed Enzymes Market application mix reflects the scale of commercial feed production by species as well as the nutritional limitations of each diet type.

Poultry is projected to reach USD 1.11 billion by 2035 and accounted for a 43.0% market share in 2025. Poultry remains the leading application because broiler, layer, and turkey feeding programs have long incorporated phytase and carbohydrase products into standardized diets. The category still offers expansion potential in developing markets, where the move from farm-mixed rations to commercial feed supports more systematic nutrient optimization.

Swine generated USD 412 million in 2025 and is projected to grow at a 6.1% CAGR from 2026 to 2035. Swine demand is supported by the widespread use of phytase in integrated pork systems and a growing interest in combinations that improve protein and energy utilization. Growth is likely to be driven by a mix of higher-quality feed management in emerging production regions and more sophisticated protease-phytase programs in established operations.

Ruminants generated USD 198 million in 2025 and are projected to represent 12.0% of total application revenue by 2035. Ruminant opportunities are more specialized than those in monogastric feed, with demand focused on calves, young animals, bypass-delivery systems, and dairy nutrition programs. Commercial progress depends on product designs that account for rumen conditions and demonstrate a clear production or nutrient-efficiency benefit within complex total mixed rations.

Aquaculture generated USD 137 million in 2025 and is projected to reach USD 409 million by 2035. Aquaculture is becoming a strategically important application as fishmeal replacement increases the use of plant-derived proteins and the nutrient constraints associated with them. Enzyme solutions that address phytate, fiber-associated polysaccharides, and protein digestibility can help producers maintain feed-conversion performance while meeting sustainability and sourcing objectives.

Pets & Equine is projected to reach USD 351 million by 2035 and grow at a 12.4% CAGR from 2026 to 2035. Premium companion-animal formulations are creating demand for digestive-support solutions that accommodate novel proteins, legumes, insect meal, and marine co-products. Product positioning in this application is less dependent on commodity feed-cost reduction and more dependent on ingredient quality, digestive performance, and differentiated nutrition claims.

Animal Feed Enzymes Market Regional Analysis

North America Animal Feed Enzymes Market Analysis

The Animal Feed Enzymes Market in North America is projected to reach USD 731 million by 2035 and grow at a 6.6% CAGR from 2026 to 2035. North America is a high-penetration market in which demand is primarily shaped by product upgrading, technical service, and expansion into selected specialty applications. Large, integrated poultry and swine systems provide a stable commercial foundation, but incremental growth increasingly depends on demonstrating superior performance under changing feed-input costs and processing conditions.

U.S.

The U.S. market generated USD 354 million in 2025 and is projected to reach USD 629 million by 2035. The U.S. is supported by large-scale broiler and swine integration, where enzyme inclusion is a routine element of commercial nutrition practice. The strongest opportunities are likely to emerge from advanced combination products, aquaculture feed development, and solutions that can be integrated into high-throughput feed-mill operations without disrupting established formulation systems.

Canada

Canada accounted for a 14.1% share of North American revenue in 2025 and is projected to grow at a 5.8% CAGR from 2026 to 2035. Canadian demand is closely linked to organized hog and poultry production and formulation practices that broadly align with those used in the United States. Its market development will depend on the economics of export-oriented animal protein production, access to technical nutrition support, and the ability of suppliers to adapt enzyme programs to local grain and oilseed-meal inputs.

Europe Animal Feed Enzymes Market Analysis

The Animal Feed Enzymes Market in Europe generated USD 351 million in 2025 and is projected to account for a 21.0% share of global revenue by 2035. Europe combines a mature commercial-feed base with a rigorous feed-additive authorization environment. The resulting market is demanding for new entrants, but its regulatory standards, technical advisory networks, and high requirements for documented efficacy reinforce the commercial importance of established suppliers with proven species-specific portfolios.

Germany

Germany generated USD 84 million in 2025 and is projected to reach USD 147 million by 2035. Germany's importance reflects its position as a major European feed-producing economy and a practical hub for distribution, formulation support, and livestock-nutrition expertise. Demand is shaped by the need to meet high performance and compliance expectations across poultry, swine, and dairy systems.

UK

The UK is projected to reach USD 130 million by 2035 and represented a 21.1% share of European revenue in 2025. The UK continues to offer a technically advanced animal-nutrition market, supported by commercial livestock operations and established feed-manufacturing capability. Maintaining product availability, regulatory continuity, and reliable technical support will remain important competitive priorities as the market operates under its own feed-additive regulatory framework.

France

France generated USD 63 million in 2025 and is projected to reach USD 110 million by 2035. France's demand base is rooted in poultry, turkey, and pig production, with enzyme selection closely connected to feed-ingredient economics and nutrient-management requirements. Suppliers that can support performance across diverse regional livestock systems will be better positioned than those relying solely on broad, undifferentiated product propositions.

Asia Pacific Animal Feed Enzymes Market Analysis

The Animal Feed Enzymes Market in Asia Pacific generated USD 508 million in 2025 and is projected to reach USD 1.02 billion by 2035. Asia Pacific combines expanding commercial-feed infrastructure with increasingly intensive livestock and aquaculture production. This combination creates a broad demand base: enzyme adoption rises as feed manufacturing becomes more formalized, while more advanced producers seek nutritional tools that accommodate alternative ingredients, higher production targets, and tighter feed-conversion expectations.

China

China generated USD 229 million in 2025 and is projected to reach USD 430 million by 2035. China's scale in compound-feed manufacturing makes it central to regional enzyme demand. Growth is supported by ongoing emphasis on feed efficiency, more structured livestock production, and the need to manage performance across high-volume poultry and swine systems using varied domestic and imported raw materials.

India

India accounted for a 15.0% share of Asia Pacific revenue in 2025 and is projected to grow at an 8.6% CAGR from 2026 to 2035. India's opportunity is tied to the growth of commercial poultry production, rising protein consumption, and the progressive replacement of informal feeding practices with formulated compound feed. Local technical service, product affordability, and the ability to demonstrate returns under diverse climatic and ingredient conditions will be important to market development.

Japan

Japan generated USD 51 million in 2025 and is projected to grow at a 5.2% CAGR from 2026 to 2035. Japan is a mature enzyme market characterized by high baseline adoption in poultry and swine nutrition. Demand is expected to center on quality assurance, consistent performance, and premium formulations that support efficient production in a market with limited scope for volume-led livestock expansion.

South Korea

South Korea is projected to account for a 5.5% share of Asia Pacific revenue by 2035 and grow at a 4.6% CAGR from 2026 to 2035. South Korea similarly reflects a mature commercial-feed environment, where suppliers compete through reliability, product support, and targeted improvements in feed efficiency. The market offers a disciplined route for technically differentiated products but fewer opportunities for basic inclusion-led growth.

Latin America Animal Feed Enzymes Market Analysis

The Animal Feed Enzymes Market in Latin America is projected to reach USD 351 million by 2035 and grow at an 8.5% CAGR from 2026 to 2035. Latin America benefits from its role in global poultry and pork production, where export competitiveness increases the value of feed efficiency and consistent animal performance. Enzyme demand is supported by technically sophisticated integrated producers, expanding commercial feed capacity, and the need to use locally available grains and protein meals effectively.

Brazil

Brazil generated USD 101 million in 2025 and is projected to reach USD 211 million by 2035. Brazil's large broiler and pork export industries create a substantial addressable market for enzyme products that improve feed conversion and nutrient utilization. Suppliers must pair product performance with local technical support, because commercial success often depends on demonstrating fit within large integrated operations and Brazilian raw-material conditions.

Mexico

Mexico is projected to reach USD 70 million by 2035 and represented a 20.2% share of Latin American revenue in 2025. Mexico's demand is anchored in commercial poultry and swine production, where cost control and dependable feed performance are persistent priorities. The market offers room for suppliers able to translate global enzyme technologies into practical programs for domestic compound-feed producers.

Middle East & Africa Animal Feed Enzymes Market Analysis

The Animal Feed Enzymes Market in Middle East & Africa generated USD 86 million in 2025 and is projected to grow at a 10.1% CAGR from 2026 to 2035. Middle East & Africa is characterized by the transition from farm-mixed and informal feeding practices toward organized compound-feed production. This structural shift expands the practical delivery channel for enzymes, particularly in poultry and aquaculture, while also creating a need for formulations suited to price-sensitive feed mills and variable raw-material supply.

South Africa

South Africa generated USD 19 million in 2025 and is projected to reach USD 45 million by 2035. South Africa is one of the region's most developed commercial enzyme markets, supported by organized feed compounding and established broiler integration. Its role as a technical and distribution center can support wider adoption across neighboring markets, although supplier success will remain tied to operational reliability and local service capability.

Saudi Arabia

Saudi Arabia generated USD 21 million in 2025 and is projected to grow at a 9.1% CAGR from 2026 to 2035. Saudi Arabia's growth is linked to investment in food security and domestic poultry production. Enzyme demand is expected to increase as commercial feed systems scale and producers seek to control feed costs while maintaining performance under conditions that can create additional stress on livestock operations.

UAE

The UAE accounted for an 18.6% share of Middle East & Africa revenue in 2025 and is projected to reach USD 38 million by 2035. The UAE combines its role as a regional trading center with demand for premium aquaculture and companion-animal nutrition products. This mix supports opportunities for specialized enzyme portfolios, although the market's commercial value will depend on targeted distribution and credible technical positioning rather than volume alone.

Animal Feed Enzymes Market Share & Competitive Landscape

The Animal Feed Enzymes Market share structure is concentrated around suppliers with fermentation capability, regulatory expertise, established application laboratories, and technical sales organizations that can support feed mills after product approval. The five leading players collectively held approximately 67% of global market revenue in 2025, reflecting the high barriers associated with enzyme development, species-specific efficacy validation, and multi-market authorization.

Novonesis held approximately 28% of global market revenue in 2025. The company's leadership reflects a broad enzyme platform, longstanding commercial relationships with feed producers, and an ability to support formulation and regulatory requirements across multiple livestock categories. Its portfolio depth positions it to compete not only in established phytase programs but also in higher-value applications requiring heat stability, multi-enzyme compatibility, and technical validation.

IFF, through Danisco Animal Nutrition, held approximately 18% of global market revenue in 2025. IFF competes through a portfolio spanning phytases, xylanases, and proteases, supported by established Axtra-branded products and feed-industry application capability. Its competitive position depends on translating enzyme activity into measurable feed-cost, nutrient-utilization, and production outcomes for integrated livestock customers.

AB Vista / AB Enzymes held approximately 11% of global market revenue in 2025. AB Vista / AB Enzymes is positioned through specialized enzyme technologies, including phytase and carbohydrase offerings, and through close engagement with poultry and swine nutrition programs. The company's ability to maintain relevance will depend on continued product differentiation, technical service, and adaptation to more varied feedstock and species requirements.

BASF, Adisseo, Kemin Industries, Elanco Animal Health, Rossari Biotech, Vland Biotech Group, Aumgene Biosciences, Sunson Industry Group, and JEFO Nutrition add to a competitive environment that spans multinational ingredient platforms and regional specialists. Competition increasingly centers on thermostability, documented nutrient-release performance, application flexibility, registration breadth, and the practical ease with which feed mills can incorporate an enzyme program into existing production lines.

Recent Industry Developments

Novonesis receives EU full-label registration for HiPhorius phytase: Novonesis announced that HiPhorius received an EU label extension covering additional poultry and pig categories, broadening the product's authorized application scope for feed producers.^{[6]dsm-firmenich. “dsm-firmenich Completes Sale of Its Stake in Feed Enzymes Alliance to Novonesis for €1.5 Billion.” dsm-firmenich.com}

Huvepharma receives EU registration for Huvezym neXo carbohydrase complex: Huvepharma announced EU registration for Huvezym neXo for poultry and pig applications, adding another commercially authorized multi-carbohydrase offering to the regional market ^{[5]Huvepharma. “Huvezym® neXo: A New Enzyme for Poultry and Swine.” huvepharma.com}.